Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically
Abstract
Ascending dopaminergic and noradrenergic neurons possess somatodendritic and terminal nicotinic cholinoceptors in the rat. Each neuronal population expresses mRNA for several types of nicotinic cholinoceptor subunit, including alpha6 and beta3. In superfused rat striatal synaptosomes, epibatidine evoked release of [3H]dopamine with similar efficacy to ACh, whereas nicotine and cytisine were weaker (70+/-6% and 58+/-6%, respectively). The four agonists were equi-efficacious in evoking [3H]noradrenaline release from hippocampal synaptosomes. Nicotine-evoked synaptosomal release was tetrodotoxin-insensitive. Somatodendritic nicotinic cholinoceptors on dopaminergic neurons were studied using a dendrosomal [3H]dopamine release assay and also in locomotor activity tests. In both assays, nicotine appeared more efficacious than epibatidine. Furthermore, with repeated nicotine exposure, the acute locomotor stimulant response to nicotine increased, whereas the epibatidine response became undetectable. In conclusion, somatodendritic nicotinic cholinoceptors located on dopaminergic neurons appear to differ pharmacologically from those on striatal dopaminergic terminals and hippocampal noradrenergic terminals.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
α3β4-containing nAChRs are believed to play a major role in nicotine-evoked NE release from the hippocampus.
“α3β4-containing nAChRs are believed to play a major role in nicotine-evoked NE release from the hippocampus [220, 221].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [221]
Cites
Paxinos, G. (1985) · Cited by 3,715 · see citing works
Glantz, S. A. (1981) · Cited by 2,636 · see citing works
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471 · see citing works
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · see citing works
Presynaptic nicotinic ACh receptors
Wonnacott, S. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10073-4 · Cited by 1,308 · see citing works
Nicotine activates and desensitizes midbrain dopamine neurons
Pidoplichko, V. I., DeBiasi, M., Williams, J. T., & Dani, J. A. (1997) · Nature · doi:10.1038/37120 · Cited by 769 · see citing works
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740 · see citing works
Luetje, C., & Patrick, J. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-03-00837.1991 · Cited by 558 · see citing works
Clarke, P. B. S., & Pert, A. (1985) · Brain Research · doi:10.1016/0006-8993(85)90456-1 · Cited by 527 · see citing works
Self-citationNisell, M., Nomikos, G. G., & Svensson, T. H. (1994) · Synapse · doi:10.1002/syn.890160105 · Cited by 510 · see citing works
Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs)
Hyttel, J. (1994) · International Clinical Psychopharmacology · doi:10.1097/00004850-199403001-00004 · Cited by 492 · see citing works
Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04461.1998 · Cited by 401 · see citing works
Identification of four classes of brain nicotinic receptors using beta2 mutant mice.
Zoli, M., Léna, C., Picciotto, M. R., & Changeux, J. (1998) · PubMed Central · doi:10.1523/jneurosci.18-12-04461.1996 · Cited by 387 · see citing works
Le Novere, N., Zoli, M., & Changeux, J. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01206.x · Cited by 385 · see citing works
Grady, S., Marks, M. J., Wonnacott, S., & Collins, A. C. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08322.x · Cited by 350 · see citing works
Purification and characterization of a nicotinic acetylcholine receptor from rat brain.
Whiting, P. J., & Lindström, J. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.595 · Cited by 301 · see citing works
Luo, S., Kulak, J. M., Cartier, G. E., Jacobsen, R. B., Yoshikami, D., Olivera, B. M., & McIntosh, J. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-21-08571.1998 · Cited by 290 · see citing works
Clarke, P. B. S., & Reuben, M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15232.x · Cited by 262 · see citing works
Self-citationPartial agonist properties of cytisine on neuronal nicotinic receptors containing the beta 2 subunit
Papke, R. L., & Heinemann, S. F. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09896-7 · Cited by 259 · see citing works
Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus
Léna, C., Changeux, J., & Mulle, C. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-06-02680.1993 · Cited by 255 · see citing works
Nirenberg, M. J., Chan, J., Liu, Y., Edwards, R. H., & Pickel, V. M. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-13-04135.1996 · Cited by 240 · see citing works
Characterization of the locomotor stimulant action of nicotine in tolerant rats
Clarke, P. B. S., & Kumar, R. C. (1983) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1983.tb10733.x · Cited by 222 · see citing works
Self-citationSchilström, B., Svensson, H. M., Svensson, T. H., & Nomikos, G. G. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00114-6 · Cited by 207 · see citing works
Schilström, B., Nomikos, G. G., Nisell, M., Hertel, P., & Svensson, T. H. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00243-1 · Cited by 206 · see citing works
RAPIER, C. M., Lunt, G. G., & Wonnacott, S. (1988) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1988.tb10582.x · Cited by 206 · see citing works
α-Conotoxin MII Blocks Nicotine-Stimulated Dopamine Release in Rat Striatal Synaptosomes
Kulak, J. M., Nguyen, T. A., Olivera, B. M., & McIntosh, J. M. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05263.1997 · Cited by 198 · see citing works
Dineley‐Miller, K., & Patrick, J. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90244-6 · Cited by 194 · see citing works
Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro
Egan, T. M., & North, R. A. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90281-2 · Cited by 169 · see citing works
Sullivan, J. P., Decker, M. W., Brioni, J. D., Donnelly‐Roberts, D. L., Anderson, D. J., Bannon, A. W., Kang, C. H., Adams, P., Piattoni-Kaplan, M., & Buckley, M. J. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23809-5 · Cited by 168 · see citing works
Charpantier, E., Barnéoud, P., Moser, P. C., Besnard, F., & Sgard, F. (1998) · Neuroreport · doi:10.1097/00001756-199809140-00033 · Cited by 166 · see citing works
A Comparison of Axonal and Somatodendritic Dopamine Release Using In Vivo Dialysis
Kalivas, P. W., & Duffy, P. (1991) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1991.tb02015.x · Cited by 165 · see citing works
Kaiser, S., Soliakov, L. S., Harvey, S. C., Luetje, C. W., & Wonnacott, S. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70031069.x · Cited by 160 · see citing works
Lü, Y., Grady, S. R., Marks, M. J., Picciotto, M. R., Changeux, J., & Collins, A. C. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37839-5 · Cited by 129 · see citing works
Sacaan, A. I., Dunlop, J. L., & Lloyd, G. K. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10508-9 · Cited by 127 · see citing works
“Orphan” α6 Nicotinic AChR Subunit Can Form a Functional Heteromeric Acetylcholine Receptor
Gerzanich, V., Kuryatov, A., Anand, R., & Lindstrom, J. M. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.2.320 · Cited by 118 · see citing works
Sorenson, E. M., Shiroyama, T., & Kitai, S. T. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00064-5 · Cited by 107 · see citing works
Pittaluga, A., & Raiteri, M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11220-2 · Cited by 103 · see citing works
Pharmacological effects of epibatidine optical enantiomers
Damaj, M. I., Creasy, K. R., Grove, A. D., et al. (1994) · Brain Research · doi:10.1016/0006-8993(94)91950-x · Cited by 97 · see citing works
Göldner, F. M., Dineley, K. T., & Patrick, J. W. (1997) · Neuroreport · doi:10.1097/00001756-199708180-00019 · Cited by 91 · see citing works
Alkondon, M., & Albuquerque, E. X. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10528-4 · Cited by 88 · see citing works
Novère, N. G. L., Zoli, M., Léna, C., Ferrari, R., Picciotto, M. R., Merlo‐Pich, E., & Changeux, J. (1999) · Neuroreport · doi:10.1097/00001756-199908200-00012 · Cited by 86 · see citing works
Nicotine-evoked [3H]5-hydroxytryptamine release from rat striatal synaptosomes
Reuben, M., & Clarke, P. B. S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00147-1 · Cited by 84 · see citing works
Self-citationEl-Bizri, H., & Clarke, P. B. S. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb14749.x · Cited by 79 · see citing works
Self-citationLouis, M. S., & Clarke, P. B. S. (1998) · Neuropharmacology · doi:10.1016/s0028-3908(98)00151-8 · Cited by 78 · see citing works
Self-citationFucile, S., Matter, J., Erkman, L., Ragozzino, D., Barabino, B., Grassi, F., Alemà, S., Ballivet, M., & Eusebi, F. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00001.x · Cited by 68 · see citing works
Benwell, M. E. M., Balfour, D. J. K., & Lucchi, H. M. (1993) · Psychopharmacology · doi:10.1007/bf02244896 · Cited by 66 · see citing works
Ligand Binding and Activation of Rat Nicotinic α4β2 Receptors Stably Expressed in HEK293 Cells
Sabey, K., Paradiso, K. G., Zhang, J., & Steinbach, J. H. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.1.58 · Cited by 66 · see citing works
Marks, M. J., Robinson, S. F., & Collins, A. C. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13086-3 · Cited by 65 · see citing works
Hippocampal nicotinic autoreceptors modulate acetylcholine release
Wilkie, G., Hutson, P. H., Stephens, M. W., et al. (1993) · Biochemical Society Transactions · doi:10.1042/bst0210429 · Cited by 58 · see citing works
Gallardo, K. A., & Leslie, F. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70020663.x · Cited by 51 · see citing works
Kelly, E., Jenner, P. G., & MARSDEN, C. D. (1985) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1985.tb05485.x · Cited by 50 · see citing works
α3, β2, and β4 Form Heterotrimeric Neuronal Nicotinic Acetylcholine Receptors in Xenopus Oocytes
Colquhoun, L. M., & Patrick, J. W. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062355.x · Cited by 49 · see citing works
Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum
Marshall, D., Soliakov, L. S., Redfern, P. H., & Wonnacott, S. (1996) · Neuropharmacology · doi:10.1016/s0028-3908(96)00117-7 · Cited by 47 · see citing works
Effects of a Novel Cholinergic Ion Channel Agonist SIB-1765F on Locomotor Activity in Rats
Menzaghi, F., Whelan, K. T., Risbrough, V. B., Rao, T. S., & Lloyd, G. K. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36403-1 · Cited by 45 · see citing works
Hefti, F. F., & LICHTENSTEIGER, W. (1978) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1978.tb10449.x · Cited by 40 · see citing works
Triphenylmethylphosphonium is an ion channel ligand of the nicotinic acetylcholine receptor.
Lauffer, L., & Hucho, F. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.7.2406 · Cited by 34 · see citing works
Marks, M. J., Bullock, A. E., & Collins, A. C. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10641-1 · Cited by 33 · see citing works
Zwart, R., Abraham, D., Oortgiesen, M., & Vijverberg, H. P. M. (1994) · Brain Research · doi:10.1016/0006-8993(94)90493-6 · Cited by 21 · see citing works
Cholinergic modulation of [3H]dopamine release from dendrosomes of rat substantia nigra
Marchi, M., Augliera, A., Codignola, A., et al. (1991) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00183000 · Cited by 17 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259 · see citing works
Cui, C., Booker, T. K., Allen, R. S., Grady, S. R., Whiteaker, P., Marks, M. J., Salminen, O., Tritto, T., Butt, C. M., Allen, W. R., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11045.2003 · Cited by 213 · see citing works
Ryan, R. E., Ross, S. A., Drago, J., & Loiacono, R. E. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703989 · Cited by 188 · see citing works
Ferrari, R., Le Novère, N., Picciotto, M. R., Changeux, J. P., & Zoli, M. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.02009.x · Cited by 132 · see citing works
Fowler, C. D., Arends, M. A., & Kenny, P. J. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32830c360e · Cited by 131 · see citing works
Mechanistic insights into nicotine withdrawal
Paolini, M., & De Biasi, M. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.075 · Cited by 66 · see citing works
Addiction‐related neuroadaptations following chronic nicotine exposure
Wills, L., & Kenny, P. J. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15356 · Cited by 61 · see citing works
- Authors
- Reuben, M., Boye, S., & Clarke, P. B. S.
- Affiliations
- McGill University (CA)
- Corresponding author
- Clarke, Paul B.S
- ORCID
- Clarke, Paul B.S
- Venue
- European Journal of Pharmacology
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 393
- Issue
- 1-3
- Pages
- 39-49
- ISSN
- 0014-2999 (ISSN-L)
- OpenAlex
- W2041566830
- Cited by
- 33
- References
- 59
- Citations by year
- 2022: 1 · 2021: 1 · 2020: 1
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Stiftung VERUM
- H. Lundbeck A/S
- Fonds de Recherche du Québec - Santé
- Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
- Keywords
- nicotinic acetylcholine receptors, dopaminergic terminals, noradrenergic terminals, dopamine release, noradrenaline release, epibatidine, nicotine, cytisine, locomotor activity, synaptosomes, striatum, hippocampus, receptor pharmacology
- MeSH terms
- Animals, Corpus Striatum, Dopamine, Hippocampus, Male, Mecamylamine, Motor Activity, Neurons, Nicotine, Norepinephrine, Pyridines, Receptors, Nicotinic, Recombinant Proteins, Synaptosomes, Tetrodotoxin, Tritium, Rats, Sprague-Dawley, Nicotinic Agonists, Nicotinic Antagonists, Bridged Bicyclo Compounds, Heterocyclic, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review